Biktarvy and Norco drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate) and Norco (acetaminophen; hydrocodone bitartrate). Common drug interactions include general physical health deterioration among females and emotional distress among males.
The phase IV clinical study analyzes what interactions people have when they take Biktarvy and Norco. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.
What is Biktarvy?
Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.
What is Norco?
Norco has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 74,063 Norco users. Check the latest studies of Norco.
45 people who take Biktarvy and Norco together, and have interactions are studied.

What are the common drug interactions of Biktarvy and Norco, by gender? *:
female:
- General physical health deterioration (weak health status)
- Hip fracture
- Injury
- Insomnia (sleeplessness)
- Lower limb fracture
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Protein urine present
- Quality of life decreased
- Renal impairment (severely reduced kidney function)
male:
- Emotional distress
- Anxiety
- Bone loss
- Blood creatinine increased
- Diarrhoea
- Hypokalaemia (low potassium)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Renal impairment (severely reduced kidney function)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Decreased activity
What are the common drug interactions of Biktarvy and Norco, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Anxiety
- Chronic kidney disease
- Emotional distress
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Tooth extraction
- Arthralgia (joint pain)
- Depression
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Bone pain
30-39:
- Bone density decreased
- Emotional distress
- Foot fracture
- Hand fracture
- Intervertebral disc degeneration (spinal disc degeneration)
- Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
- Tooth loss
40-49:
- Emotional distress
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chronic kidney disease
- Osteonecrosis (death of bone)
- Renal impairment (severely reduced kidney function)
- Bone density decreased
- Tooth loss
- Blood creatinine increased
- Hip arthroplasty
50-59:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Emotional distress
- Anxiety
- Bone density decreased
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Hypokalaemia (low potassium)
- Osteonecrosis (death of bone)
- Tooth loss
- Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
60+:
- Emotional distress
- Bone density decreased
- Abdominal discomfort
- Bone fragmentation
- Death
- Diarrhoea
- Hip fracture
- Impaired healing
- Insomnia (sleeplessness)
- Mouth ulceration (mouth ulcers)
What are the existing conditions these people have? *
- High Blood Pressure: 4 people, 8.89%
- High Blood Cholesterol: 4 people, 8.89%
- Depression: 4 people, 8.89%
* Approximation only. Some reports may have incomplete information.
Do you take Biktarvy and Norco?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Biktarvy and Norco:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Biktarvy:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Norco:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Biktarvy and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Norco and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate and acetaminophen; hydrocodone bitartrate (the active ingredients of Biktarvy and Norco, respectively), and Biktarvy and Norco (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Norflex and Potassium - 3 seconds ago
- Deja Vu and drugs of ingredients of venlafaxine hydrochloride - 5 seconds ago
- Eczema and Dementia - 6 seconds ago
- Fluoxetine and Tic for Women aged 20-29 - 8 seconds ago
- Keveyis and Weakness for Women aged 50-59 - 9 seconds ago
- Keveyis and Asthenia for Women aged 50-59 - 10 seconds ago
- Keveyis and Muscle Fatigue for Women aged 50-59 - 10 seconds ago
- Keveyis and Muscular Weakness for Women aged 50-59 - 10 seconds ago
- Keveyis and Lack Of Strength, Muscle Weakness, Weakness for Women aged 50-59 - 11 seconds ago
- Keveyis and Muscle Weakness for Women aged 50-59 - 11 seconds ago